These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 35314352)
1. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience. Olszowska-Zaremba N; Zagożdżon R; Gozdowska J Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience. Olszowska-Zaremba N; Gozdowska J; Zagożdżon R Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test. Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026 [TBL] [Abstract][Full Text] [Related]
4. The clinical utility and thresholds of virtual and Halifaster flow crossmatches in lung transplantation. Hiho SJ; Levvey B; Carroll R; Nicolson I; Mihaljcic M; Diviney MB; Snell GI; Sullivan LC; Westall GP HLA; 2022 Jun; 99(6):580-589. PubMed ID: 35340124 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation. Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055 [TBL] [Abstract][Full Text] [Related]
8. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation. Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul. Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054 [TBL] [Abstract][Full Text] [Related]
10. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history? Tafulo S; Osório E; Mendes C; Liwski R Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522 [TBL] [Abstract][Full Text] [Related]
11. Fallacies of a purely virtual platform: Virtual plus reality versus virtual reality - A case study. Gnanaraj J; Doss SA; Stephen S; Pratheeba M; Daniel D Transpl Immunol; 2023 Dec; 81():101956. PubMed ID: 37952899 [TBL] [Abstract][Full Text] [Related]
12. Positive virtual crossmatch with negative flow crossmatch results in two cases. Jacob EK; De Goey SR; Gandhi MJ Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997 [TBL] [Abstract][Full Text] [Related]